Novato, CA, United States

Ultragenyx Pharmaceutical

www.ultragenyx.com
Novato, CA, United States
SEARCH FILTERS
Time filter
Source Type

Patent
Ultragenyx Pharmaceutical | Date: 2016-10-26

The present invention relates to compositions and methods for treating sialic acid deficiencies comprising extended release formulations.


Patent
Ultragenyx Pharmaceutical and Kyowa Hakko Kirin Co. | Date: 2017-04-12

The present invention provides compositions and methods for treating a hypophosphatemic disorder, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition containing an anti-FGF23 ligand, wherein the dosing regimen of the pharmaceutical is designed to reach effective and efficient control of FGF23 activity.


Patent
Ultragenyx Pharmaceutical | Date: 2016-09-14

The present invention includes crystalline forms of N-acetylneuraminic acid (NeuAc) and crystalline forms of salts and/or solvates of N-acetylneuraminic acid (NeuAc). Furthermore, the present invention provides compositions comprising these crystalline forms and therapeutic use of the crystalline forms.


Patent
Ultragenyx Pharmaceutical | Date: 2016-12-19

The present invention relates to compositions and methods for treating sialic acid deficiencies comprising extended release formulations.


Patent
Ultragenyx Pharmaceutical | Date: 2016-10-28

Methods and compositions for the treatment or prevention of amyloidosis are provided. In some embodiments, the methods comprise administering to the subject a therapeutically effective amount of at least one catabolic enzyme or a biologically active fragment thereof. Such methods and compositions may be employed to reduce, prevent, degrade and/or eliminate amyloid formation in the lysosome and/or extracellularly.


Patent
Ultragenyx Pharmaceutical | Date: 2017-01-11

The present application relates to sialylated glycoprotein compositions and methods of their use in treating various conditions and disorders.


Patent
Ultragenyx Pharmaceutical | Date: 2015-09-10

The present application relates to sialylated glycoprotein compositions and methods of their use in treating various conditions and disorders.


Patent
Ultragenyx Pharmaceutical | Date: 2015-03-05

The present application relates to sialylated glycoprotein compositions and methods of their use in treating various conditions and disorders.


Patent
Ultragenyx Pharmaceutical | Date: 2015-11-18

The present invention provides sialic acid analogs and their compositions useful for the treatment of sialic acid deficiencies.


Patent
Ultragenyx Pharmaceutical | Date: 2016-08-30

The present application relates to sialylated glycoprotein compositions and methods of their use in treating various conditions and disorders.

Loading Ultragenyx Pharmaceutical collaborators
Loading Ultragenyx Pharmaceutical collaborators